UroGen Pharma ( NASDAQ: URGN) announced on Wednesday that the U.S. FDA has scheduled an Oncologic Drugs Advisory Committee ...

From dehydration and UTIs to kidney stones and medication effects, discover the common reasons behind cloudy urine and when ...

Scientists develop urine test that detects prostate cancer more accurately than blood tests, offering men a painless option ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation ...

For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive ...

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition ...

"EC approves AstraZeneca’s Calquence combo to treat MCL" was originally created and published by Pharmaceutical Technology, a ...